Treasure International proposes to privatise OUE Healthcare at 0.050 Singapore dollars per share

SGX Filings
Yesterday

Singapore – Aug, 24 2026 – Treasure International Holdings Pte. Ltd., a wholly owned unit of OUE Limited, has launched a scheme of arrangement to acquire all shares it does not already own in OUE Healthcare Limited for 0.050 Singapore dollars in cash per share.

The offer values each share at a 28.2% premium to OUE Healthcare’s last traded price of 0.039 Singapore dollars on Aug, 21 2026, the final trading day before the announcement. It also represents premiums of 37.5%, 36.1%, 42.1% and 51.1% over the one-, three-, six- and twelve-month volume-weighted average prices, respectively, and stands 2.5% above the company’s unaudited net asset value of 0.0488 Singapore dollars per share as at Jun, 30 2026.

The offeror already controls about 89.68% of OUE Healthcare’s issued shares. Approval of the scheme requires at least 75% in value and a majority in number of votes cast by independent shareholders at a forthcoming meeting, as well as regulatory and court clearances.

OUE Healthcare shares have averaged daily trading volume equal to roughly 0.05% of issued equity during the 12 months to Aug, 21 2026, with 16 non-trading days in that period. The proposed privatisation is aimed at giving minority investors an exit at a premium while allowing the company to pursue longer-term strategies away from public-market pressures.

OUE Healthcare will appoint an independent financial adviser to guide its recommending directors, and full details of the scheme will be provided in a circular to shareholders. If approved, OUE Healthcare will become a wholly owned subsidiary of Treasure International and will seek delisting from the Singapore Exchange.

Maybank Securities Pte. Ltd. is acting as financial adviser to the offeror.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10